CNCR

Loncar Cancer Immunotherapy ETF

CNCR | NASDAQ
$9.02
$0.00 (0.00%)
Nov 2, 2026, 10:11 AM ET · Market open
Total Holdings
31
Top 10 Holdings
34.44%
Top Sector
Healthcare (96.58%)

Sector Allocation

Healthcare
96.58%
Financial Services
3.29%
Cash & Others
0.13%
Symbol Name Price % Change Shares % Weight
TIL
Instil Bio, Inc.
- - 93.23K 3.59%
REPL
Replimune Group, Inc.
- - 47.19K 3.54%
IOVA
Iovance Biotherapeutics, Inc.
- - 67.49K 3.47%
ZYME
Zymeworks Inc.
- - 41.55K 3.45%
ARGX
argenx SE
- - 5.06K 3.42%
GMAB
Genmab A/S
- - 35.79K 3.42%
AZN
AstraZeneca PLC
- - 26.54K 3.39%
BMY
Bristol-Myers Squibb Company
- - 23.17K 3.39%
CRSP
CRISPR Therapeutics AG
- - 12.62K 3.39%
MRK
Merck & Co., Inc.
- - 20.51K 3.37%
XNCR
Xencor, Inc.
- - 41.93K 3.37%
NKTR
Nektar Therapeutics
- - 87.54K 3.37%
REGN
Regeneron Pharmaceuticals, Inc.
- - 2.94K 3.36%
GILD
Gilead Sciences, Inc.
- - 22.54K 3.33%
FATE
Fate Therapeutics, Inc.
- - 17.66K 3.33%
RCUS
Arcus Biosciences, Inc.
- - 62.77K 3.32%
ATRA
Atara Biotherapeutics, Inc.
- - 108.6K 3.30%
ALLO
Allogene Therapeutics, Inc.
- - 60.62K 3.29%
TRIL
Trillium Therapeutics Inc.
- - 160.99K 3.29%
RUBY
Rubius Therapeutics, Inc.
- - 59.29K 3.29%
Page 1 of 2

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.